+ All Categories
Home > Documents > NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based...

NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based...

Date post: 26-Jan-2020
Category:
Upload: others
View: 4 times
Download: 0 times
Share this document with a friend
17
NK/ADCC Target cell Visualization Assay (TVA )
Transcript
Page 1: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

NK/ADCC

Target cell

Visualization Assay

(TVA™)

Page 2: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

Background

ADCC

NK

Page 3: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

Dead Target Cells

Foundation of NK-TVA™ Assay:

Fluorescently-stained target cells

lose the dye after they die

Live Target Cells

Tumor cells imaged before (left) and after (right) undergoing apoptosis

Page 4: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

Measuring NK activity in vitro

Page 5: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

TVA™ Assay:

Plate layout

Page 6: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

NK-TVA™

Representative images, 96-well assay

50:1 (65% killing) 12:1 (43% killing) 6:1 (29% killing) 0:1

99 197 279 159

When NK cells are active in PBMC,

increased numbers of target cells are

lysed as the number of PBMC increase.

The dose response curve on the left is

automatically generated by the NK-TVA™

instrument.

Page 7: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

Single-Cell Imaging

The CTL Analyzer is capable of single-cell imaging in microtiter plates

Page 8: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

-20

0

20

40

60

80

100

100:1 50:1 25:1 12:1 6:1 Media

Day 1

Day 2

Day 3

-20

0

20

40

60

80

100

100:1 50:1 25:1 12:1 6:1 Media

Day 1

Day 2

Day 3

-40

-20

0

20

40

60

80

100

100:1 50:1 25:1 12:1 6:1 Media

Day 1

Day 2

Day 3

Effector : Target Ratio

% L

ys

is o

f Ta

rge

t C

ell

s

Precision –

Repeatability on multiple days

Cryopreserved PBMC of three human

donors from the CTL ePBMC® Library

were each tested in three repeat

experiments. NK-activity characterized

PBMC are offered by CTL as positive

and negative controls, or for assay

development, qualification and validation.

Page 9: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

Mini TVA™

Terasaki plate-based counting

permits 1:10 miniaturization vs.

the 96-well TVA™

– Assay is carried out in Terasaki plates

(20μl/well)

– Counting is performed using

ImmunoSpot® TVA™ Software

Mini TVA™ is Ideal when limited

numbers of PBMC are available, e.g.,

pediatric or oncologic samples, HIV, etc.

Page 10: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

90:1 (53% killing) 45:1 (28% killing) 22:1 (32% killing)

11:1 (20% killing) 0:1

E:T Ratio

E:T Ratio

Mini TVA™:

Target cells in Terasaki plates

Page 11: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

% L

ys

is o

f Ta

rge

t C

ell

s

Effector : Target Ratio

0

20

40

60

100:1 50:1 25:1 12:1 6:1

0

20

40

60

80

100:1 50:1 25:1 12:1

-20

0

20

40

60

80

100:1 50:1 25:1 12:1 6:1

TVA™ in Terasaki vs. 96-well plates

testing three different donors

Page 12: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

Conventional Approaches (#1)

Chromium Release Assay

• Target cells are loaded with radioactive Chromium

• Measure of released radioactivity is correlated

to % killing

Lactate Dehydrogenase Assay

• Target cells, upon lysing, release enzymes:

Lactate Dehydrogenase

• Enzymes react with Formazan to elicit a purple color

• Colorimetric measurements of Formazan is

correlated to % killing

•Both are indirect, semi-quantitative, and

have low signal-to-noise performance

•Cr release involves radioactive

components and waste

Page 13: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

Conventional Approaches (#2)

Imaging-based vs. flow cytometry-based

detection of target cell lysis

• High-throughput, much faster

• Fully-automated data analysis

• GLP, audit trails automatically provided

• Fewer effector cells (much fewer for Mini TVA™)

• Essentially maintenance-free instrument

• More cost-effective

Page 14: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

Advantages of TVA™ over

Conventional NK Assays

• Non-radioactive

• Fewer effector cells needed

• Direct detection of target

cells by imaging resulting in

quantitative analysis

• Automated scanning, counting,

and analysis

Page 15: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

TVA™ vs.

Chromium Release

Page 16: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

Calcein green Calcein Red Orange Calcein Violet

Multicolor TVA™ mode

Page 17: NK/ADCC Target cell Visualization Assay (TVA NK-TVA2.pdf · Mini TVA™ Terasaki plate-based counting permits 1:10 miniaturization vs. the 96-well TVA™ –Assay is carried out in

Contact us today to learn more about

The NK Target cell

Visualization Assay

TVA™

by

www.immunospot.com


Recommended